Abstract submissions on drug development methodology, clinical research, and neuropsychopharmacology
are welcome.
The CNS Summit will have dedicated poster sessions. It is requested that an author
of each accepted abstract be available during the poster sessions.
Posters will undergo peer review.
Accepted abstracts will be published in the journal Innovations in Clinical Neuroscience,
which is indexed on PubMed Central, PsycINFO, EMBASE and SCOPUS.
Abstracts should be submitted by September 30th, 2013.
Submission requirements are as follows:
Abstract should include title, authors, affiliations, background, methods, results,
and conclusions sections as appropriate. The word limit for abstract text is 250
words; include two keywords; list of full disclosure of conflicts of interest for
each author.
Once your abstract has been approved, you will be responsible for supplying your
own poster. Please note the dimensions of your poster should not exceed 48”
by 96” in total.
The organizers will provide the poster board and the necessary equipment needed
to affix your poster.
Please direct submissions and any submission questions to secretariat@cnssummit.org
